Alba Vidal-Torres, PhD

Senior Researcher, In Vivo Efficacy
WeLab Barcelona
Barcelona, Catalonia, Spain

Presentation(s):

• Poster Number-63 - ADV-502, a Novel Dual Sigma-1 Receptor Antagonist and Mu-Opioid Receptor Agonist for the Treatment of Pain: II. Tolerance and Opioid-Induced Hyperalgesia

  Poster Abstracts